Trials / Conditions / EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
5 registered clinical trials studyying EGFR Mutation Positive Advanced Non Small Cell Lung Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib NCT06982924 | Shanghai Chest Hospital | Phase 2 |
| Recruiting | ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation NCT06775743 | Fudan University | Phase 2 |
| Recruiting | A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung C NCT06631989 | Wayshine Biopharm, Inc. | Phase 1 / Phase 2 |
| Terminated | Gefitinib Long-term Survivor Study NCT02932345 | AstraZeneca | — |
| Completed | Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Adv NCT02228369 | AstraZeneca | Phase 1 |